InsidersTradesSigma
Explore the detailed record of transactions filed by Miyashita Akiko Moni, Director. Officer active across 1 company, notably Halozyme Therapeutics, INC.. Cumulatively, 1 disclosures have been published. History available since 5 May 2022. The latest transaction was filed on 5 May 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration
Akiko Moni Miyashita is a Board Member at Halozyme Therapeutics, Inc. She plays an essential role in the strategic direction of the company, overseeing operations and contributing to decision-making. Miyashita brings significant expertise in the biopharmaceutical sector, enriching discussions within the board.